Idaho’s bioscience industry is an innovative and growing component of the overall U.S. economy. With a track record of generating high-quality jobs and steady growth, the bioscience industry has been a consistent engine for our economy and a key strength during past economic recessions. American innovation in bioscience helps support state and local communities in a variety of ways ranging from job creation, construction, tax revenues, and other economic impact values.

Driven by small-company innovators, the bioscience industry has also mobilized in an unprecedented manner to address the global COVID-19 pandemic, while continuing to develop other life-saving and life-enhancing products and services for the U.S. and the world. America’s bioscience industry as an innovator and economic driver has never been more important, both for our health and our economic stability.

Total Number of Facilities in Idaho 6
Jobs Directly Supported by the Industry in Idaho 8031
Annual Average Wage
$89521
Total Clinical Trials
217
Dollar Amount Invested in Clinical Trials
$58.7 Million
Clinical Trial Participants
4139
Total Clinical Trial Economic Impact
$144.1 Million

View Facilities By District

District Total Facilities in District View Facilities in District
ID01 3 BASF Corp (A) (2)

Bayer (H)

ID02 3 Bayer (H)

Idaho Technology Council (O)

Simplot Plant Sciences (A)